Ensign Peak Advisors’s Orthofix Medical OFIX Stock Holding History

Ensign Peak Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,150	Closed	-$98K	–	2081
2022 Q3	$98K	Hold	5,150	–	–	﹤0.01%	2097
2022 Q2	$121K	Hold	5,150	–	–	﹤0.01%	1925
2022 Q1	$168K	Hold	5,150	–	–	﹤0.01%	1923
2021 Q4	$160K	Sell	5,150 -2,650	-34%	-$88.6K	﹤0.01%	1974
2021 Q3	$297K	Hold	7,800	–	–	﹤0.01%	1707
2021 Q2	$313K	Hold	7,800	–	–	﹤0.01%	1675
2021 Q1	$338K	Hold	7,800	–	–	﹤0.01%	1658
2020 Q4	$335K	Hold	7,800	–	–	﹤0.01%	1663
2020 Q3	$243K	Hold	7,800	–	–	﹤0.01%	1650
2020 Q2	$250K	Hold	7,800	–	–	﹤0.01%	1561
2020 Q1	$218K	Buy	7,800 +1,500	+24%	+$58K	﹤0.01%	1524
2019 Q4	$291K	Buy	+6,300	New	+$296K	﹤0.01%	1593

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Ensign Peak Advisors's OFIX Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Orthofix Medical (OFIX) in Q4 2022, closing a stake of 5,150 shares — an estimated $98K sold.

Ensign Peak Advisors first reported a position in OFIX in Q4 2019 and held it in 12 quarters. The position peaked at $338K in Q1 2021. 153 funds tracked by Wall St. Rank hold OFIX as of Q4 2022.

Ensign Peak Advisors reported no remaining Orthofix Medical position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 5,150 Orthofix Medical shares in Q4 2022, an estimated $98K.
Ensign Peak Advisors first reported a position in Orthofix Medical in Q4 2019 and held it in 12 quarters.
Ensign Peak Advisors's Orthofix Medical position peaked at $338K in Q1 2021.
153 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.